(Q41666547)

6 October 2017

title

Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses (English)

1 reference

6 October 2017

Ziv Kaner

1

1 reference

6 October 2017

David E Ochayon

2

1 reference

6 October 2017

Galit Shahaf

3

1 reference

6 October 2017

Boris M Baranovski

4

1 reference

6 October 2017

Nofar Bahar

5

1 reference

6 October 2017

Mark Mizrahi

6

1 reference

6 October 2017

Eli C Lewis

7

1 reference

6 October 2017

language of work or name

English

0 references

publication date

10 November 2014

1 reference

Journal of Infectious Diseases

6 October 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 October 2017

volume

211

1 reference

6 October 2017

issue

9

1 reference

6 October 2017

page(s)

1489-1498

1 reference

Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Expanding the clinical indications for α(1)-antitrypsin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Immunodesign of experimental sepsis by cecal ligation and puncture

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Blockade of tissue factor: treatment for organ injury in established sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

The disconnect between animal models of sepsis and human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Cytokine profile during the clinical course of toxic shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

The "cytokine profile": a code for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

α-1-antitrypsin inhibits acute liver failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Alpha1-antitrypsin protects beta-cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Apoptosis and caspases regulate death and inflammation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Anti-inflammatory response is associated with mortality and severity of infection in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

An acute phase protein ready to go therapeutic for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Streptomyces erythraeus trypsin inactivates α1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

Bacterial proteolytic complexes as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU620

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIU620

1 reference

6 October 2017

1 reference